|
ACAT1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.76509926067092E-11 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.91810012317717E-10 |
| Normal-vs-Stage2 |
7.113200E-01 |
| Normal-vs-Stage3 |
5.55111512312578E-16 |
| Normal-vs-Stage4 |
1.63169477929159E-12 |
| Stage1-vs-Stage2 |
1.070100E-02 |
| Stage1-vs-Stage3 |
1.271810E-01 |
| Stage1-vs-Stage4 |
1.616490E-02 |
| Stage2-vs-Stage3 |
2.057600E-03 |
| Stage2-vs-Stage4 |
6.582300E-04 |
| Stage3-vs-Stage4 |
2.867000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.24122934153093E-13 |
| Normal-vs-AfricanAmerican |
4.96640000235971E-08 |
| Normal-vs-Asian |
3.34460000028791E-07 |
| Caucasian-vs-AfricanAmerican |
9.161200E-01 |
| Caucasian-vs-Asian |
5.024800E-01 |
| AfricanAmerican-vs-Asian |
5.613000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.10389999996574E-06 |
| Normal-vs-Female |
3.84480225434913E-11 |
| Male-vs-Female |
7.740000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.18550000506002E-08 |
| Normal-vs-Age(41-60Yrs) |
1.94539939712968E-11 |
| Normal-vs-Age(61-80Yrs) |
1.57087999999028E-05 |
| Normal-vs-Age(81-100Yrs) |
1.75624999999568E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.244000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.909800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.518640E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.634300E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.844790E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.108000E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.915780E-01 |
| Classical-VS-Follicular |
1.91950999999246E-05 |
| Classical-VS-Other |
6.416600E-01 |
| Classical-VS-Normal |
1.62481139653892E-12 |
| Tall-VS-Follicular |
1.95449999995656E-06 |
| Tall-VS-Other |
8.749400E-01 |
| Tall-VS-Normal |
1.62458935193399E-12 |
| Follicular-VS-Other |
1.462110E-03 |
| Follicular-VS-Normal |
8.504600E-01 |
| Other-VS-Normal |
4.18300000000205E-05 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.40829999994985E-07 |
| Normal-vs-N1 |
<1E-12 |
| N0-vs-N1 |
2.06700000005E-07 |
|
|
